Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease

American Journal of Cardiology

Volumn 115, Issue 4, 2015, Pages 441-446

  Van De Woestijne, Anton P ^a   Van Der Graaf, Yolanda ^a   Westerink, Jan ^a   Nathoe, Hendrik M ^a   Visseren, Frank L J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; CERIVASTATIN; CHOLESTEROL; FLUINDOSTATIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

ABDOMINAL AORTA ANEURYSM; ADULT; AGE; ARTICLE; BODY MASS; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE; BLOOD; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; FOLLOW UP; INCIDENCE; MIDDLE AGED; NETHERLANDS; RISK FACTOR; VASCULAR DISEASES;

BODY MASS INDEX; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; INSULIN RESISTANCE; MALE; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; RISK FACTORS; VASCULAR DISEASES;

EID: 84921882757     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.11.021     Document Type: Article

References (24)

1. C. Baigent, L. Blackwell, J. Emberson, L.E. Holland, C. Reith, N. Bhala, R. Peto, E.H. Barnes, A. Keech, J. Simes, and R. Collins Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials Lancet 376 2010 1670 1681
2. Z. Reiner, A.L. Catapano, B.G. De, I. Graham, M.R. Taskinen, O. Wiklund, S. Agewall, E. Alegria, M.J. Chapman, P. Durrington, S. Erdine, J. Halcox, R. Hobbs, J. Kjekshus, P.P. Filardi, G. Riccardi, R.F. Storey, and D. Wood ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur Heart J 32 2011 1769 1818
3. Executive Summary of the Third report of the National cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in Adults (Adult treatment Panel III) JAMA 285 2001 2486 2497
4. P.M. Ridker, E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto Jr., J.J. Kastelein, W. Koenig, P. Libby, A.J. Lorenzatti, J.G. MacFadyen, B.G. Nordestgaard, J. Shepherd, J.T. Willerson, and R.J. Glynn Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial Lancet 373 2009 1175 1182
5. N. Sattar, D. Preiss, H.M. Murray, P. Welsh, B.M. Buckley, A.J. de Craen, S.R. Seshasai, J.J. McMurray, D.J. Freeman, J.W. Jukema, P.W. Macfarlane, C.J. Packard, D.J. Stott, R.G. Westendorp, J. Shepherd, B.R. Davis, S.L. Pressel, R. Marchioli, R.M. Marfisi, A.P. Maggioni, L. Tavazzi, G. Tognoni, J. Kjekshus, T.R. Pedersen, T.J. Cook, A.M. Gotto, M.B. Clearfield, J.R. Downs, H. Nakamura, Y. Ohashi, K. Mizuno, K.K. Ray, and I. Ford Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials Lancet 375 2010 735 742
6. D. Preiss, S.R. Seshasai, P. Welsh, S.A. Murphy, J.E. Ho, D.D. Waters, D.A. DeMicco, P. Barter, C.P. Cannon, M.S. Sabatine, E. Braunwald, J.J. Kastelein, J.A. de Lemos, M.A. Blazing, T.R. Pedersen, M.J. Tikkanen, N. Sattar, and K.K. Ray Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis JAMA 305 2011 2556 2564
7. K.L. Wang, C.J. Liu, T.F. Chao, C.M. Huang, C.H. Wu, S.J. Chen, T.J. Chen, S.J. Lin, and C.E. Chiang Statins, risk of diabetes, and implications on outcomes in the general population J Am Coll Cardiol 60 2012 1231 1238
8. A.L. Culver, I.S. Ockene, R. Balasubramanian, B.C. Olendzki, D.M. Sepavich, J. Wactawski-Wende, J.E. Manson, Y. Qiao, S. Liu, P.A. Merriam, C. Rahilly-Tierny, F. Thomas, J.S. Berger, J.K. Ockene, J.D. Curb, and Y. Ma Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative Arch Intern Med 172 2012 144 152
9. D.D. Waters, J.E. Ho, S.M. Boekholdt, D.A. DeMicco, J.J. Kastelein, M. Messig, A. Breazna, and T.R. Pedersen Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes J Am Coll Cardiol 61 2013 148 152
10. N.L. Zaharan, D. Williams, and K. Bennett Statins and risk of incident diabetes in a primary care population Br J Clin Pharmacol 75 2013 1118 1124
11. P.M. Ridker, A. Pradhan, J.G. MacFadyen, P. Libby, and R.J. Glynn Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial Lancet 380 2012 565 571
12. P.C. Simons, A. Algra, M.F. van de Laak, D.E. Grobbee, and G.Y. van der Second manifestations of ARTerial disease (SMART) study: rationale and design Eur J Epidemiol 15 1999 773 781
13. T.C. Weng, Y.H. Yang, S.J. Lin, and S.H. Tai A systematic review and meta-analysis on the therapeutic equivalence of statins J Clin Pharm Ther 35 2010 139 151
14. R. Hou, and A.C. Goldberg Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety Endocrinol Metab Clin North Am 38 2009 79 97
15. A.A. Carter, T. Gomes, X. Camacho, D.N. Juurlink, B.R. Shah, and M.M. Mamdani Risk of incident diabetes among patients treated with statins: population based study BMJ 346 2013 f2610
16. F. Guerrero-Romero, L.E. Simental-Mendia, M. Gonzalez-Ortiz, E. Martinez-Abundis, M.G. Ramos-Zavala, S.O. Hernandez-Gonzalez, O. Jacques-Camarena, and M. Rodriguez-Moran The product of triglycerides and glucose, a simple measure of insulin sensitivity J Clin Endocrinol Metab 95 2010 3347 3351
17. B. Mihaylova, J. Emberson, L. Blackwell, A. Keech, J. Simes, E.H. Barnes, M. Voysey, A. Gray, R. Collins, and C. Baigent The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials Lancet 380 2012 581 590
18. K.L. Wang, C.J. Liu, T.F. Chao, S.J. Chen, C.H. Wu, C.M. Huang, C.C. Chang, K.F. Wang, T.J. Chen, S.J. Lin, and C.E. Chiang Risk of new-onset diabetes mellitus versus reduction in cardiovascular events with statin therapy Am J Cardiol 113 2014 631 636
19. D.T. Ko, H.C. Wijeysundera, C.A. Jackevicius, A. Yousef, J. Wang, and J.V. Tu Diabetes mellitus and cardiovascular events in older patients with myocardial infarction prescribed intensive-dose and moderate-dose statins Circ Cardiovasc Qual Outcomes 6 2013 315 322
20. S.F. Nielsen, and B.G. Nordestgaard Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study Lancet Diabetes Endocrinol 2 2014 894 900
21. J.A. Dorresteijn, S.M. Boekholdt, G.Y. van der, J.J. Kastelein, J.C. LaRosa, T.R. Pedersen, D.A. DeMicco, P.M. Ridker, N.R. Cook, and F.L. Visseren High-dose statin therapy in patients with stable coronary artery disease: treating the right patients based on individualized prediction of treatment effect Circulation 127 2013 2485 2493
22. G.M. Reaven Insulin resistance, the insulin resistance syndrome, and cardiovascular disease Panminerva Med 47 2005 201 210
23. M.A. Abdul-Ghani, D.F. Tripathy, and R.A. DeFronzo Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose Diabetes Care 29 2006 1130 1139
24. G. Corrao, B. Ibrahim, F. Nicotra, D. Soranna, L. Merlino, A.L. Catapano, E. Tragni, M. Casula, G. Grassi, and G. Mancia Statins and the risk of diabetes: evidence from a large population-based cohort study Diabetes Care 37 2014 2225 2232